The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: finasteride     Quarter: 2016Q3

Total Drug/Injury Combinations: 560     Number of Pages: 28

DRUGNAME PT EventCount
FINASTERIDE. Nerve compression 2 view events
FINASTERIDE. Nervous system disorder 2 view events
FINASTERIDE. Obsessive-compulsive disorder 2 view events
FINASTERIDE. Orchidopexy 2 view events
FINASTERIDE. Oropharyngeal pain 2 view events
FINASTERIDE. Overweight 2 view events
FINASTERIDE. Pain in jaw 2 view events
FINASTERIDE. Paradoxical drug reaction 2 view events
FINASTERIDE. Paranoia 2 view events
FINASTERIDE. Patellofemoral pain syndrome 2 view events
FINASTERIDE. Penile curvature 2 view events
FINASTERIDE. Penile prosthesis insertion 2 view events
FINASTERIDE. Product substitution issue 2 view events
FINASTERIDE. Product use issue 2 view events
FINASTERIDE. Prostate cancer 2 view events
FINASTERIDE. Prostatic obstruction 2 view events
FINASTERIDE. Prostatomegaly 2 view events
FINASTERIDE. Pruritus genital 2 view events
FINASTERIDE. Psoriatic arthropathy 2 view events
FINASTERIDE. Psychiatric symptom 2 view events

Total Drug/Injury Combinations: 560     Number of Pages: 28

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)